Actelion Ltd.

Actelion Ltd.
Stock Exchange Other OTC
EPS
$6.77
Market Cap
-
Shares Outstanding
106.4 M
Public Float
-
Actelion Ltd. ADR
Stock Exchange Other OTC
EPS
-
Market Cap
-
Shares Outstanding
429.32 M
Public Float
-

Profile

Address
Gewerbestrasse 16
Allschwil Basel-Landschaft (Basle Country) 4123
Switzerland
Employees -
Website http://www.actelion.com
Updated 07/08/2019
Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical drugs. It is a biopharmaceutical company, which focuses on the drug discovery, development, registration, production and commercialization of innovative drugs for diseases with significant unmet medical needs. Its portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.

Financials

View All
Created with Highcharts 5.0.14Actelion Ltd.Net Income. Fiscal year is January-December. All values CHF Millions.303303453453594594552552696696201220132014201520160200400600800
Created with Highcharts 5.0.14Actelion Ltd.Sales/Revenue. Fiscal year is January-December. All values CHF Millions.1 7281 7281 7861 7861 9581 9582 0452 0452 4182 41820122013201420152016050010001500200025003000

Ludo Ooms
Chairman
Andrea Ostinelli
Director